Myopathies inflammatoires

Myopathies inflammatoires

  
Dieval C et al. Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes Medicine (Baltimore). 2015 Jul;94(26):e798.Lire le résumé
Ruperto N et al. Paediatric Rheumatology International Trials Organisation (PRINTO). Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juveniledermatomyositis: a randomised trial. Lancet. 2015 Nov 27.Lire le résumé
Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J Intern Med. juill 2016;280(1):24‑38.Lire le résumé
Habers GEA et al. Muscles in motion: a randomized controlled trial on the feasibility, safety and efficacy of an exercise training programme in children and adolescents with juvenile dermatomyositis. Rheumatol Oxf Engl. juill 2016;55(7):1251‑62.Lire le résumé
Pinal-Fernandez I et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 20 sept 2016Lire le résumé
Deakin CT et al. UK Juvenile Dermatomyositis Research Group. Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis. Arthritis Rheumatol. 2016 Nov;68(11):2806-2816. 2016 Oct 9.Lire le résumé
Uruha A et al. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis. Neurology. 2016 Dec 30.Lire le résumé
Arouche-Delaperche Louiza et al. Pathogenic Role of Anti-SRP and Anti-HMGCR Antibodies in Necrotizing Myopathies: Myofiber Atrophy and Impairment of Muscle Regeneration in Necrotizing Autoimmune Myopathies. Annals of Neurology, February 22, 2017.Lire le résumé
Aggarwal R et al. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. mai 2017;76(5):792‐801.Lire le résumé
Mamyrova G et al. Environmental factors associated with disease flare in juvenile and adult dermatomyositis.Rheumatology (Oxford). 2017 Apr 21. Lire le résumé
Bachasson D et al. Physical Activity Monitoring: A Promising Outcome Measure in Idiopathic Inflammatory Myopathies. Neurology. 2017 May 31Lire le résumé
Meyer A et al. IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis. Acta Neuropathol (Berl). 2017 Jun 16Lire le résumé
Suzuki S et al. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology. 18 août 2017Lire le résumé
Lilleker JB et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2017 Aug 30Lire le résumé
Lundberg IE et al. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile
Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol Hoboken NJ. 2017 Oct 27
Lire le résumé
Varnier GC. et al. Development and testing of a hybrid measure of
muscle strength in juvenile dermatomyositis for use in routine care. Arthritis Care Res
(Hoboken). 2017 Dec 15.
Lire le résumé
Allenbach Y. et al. Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement. Neurology. 2018 Jan 12.Lire le résumé
Silverberg JI et al. Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample. Rheumatology (Oxford). 2018 Jan 24. Lire le résumé
Aouizerate J, De Anton
io M et al. Muscle ischaemia associated with NXP2 autoantibodies: a severe
subtype of juvenile dermatomyositis.. Rheumatology (Oxford). 2018 Feb 20
Lire le résumé
Yeker RM, Pinal-Fernandez I, Kishi T, Pak K, Targoff IN, Miller FW, et al. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Annals of the Rheumatic Diseases, 2018 May 7Lire le résumé
Ladislau L, Suárez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M, et al. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain. 2018 Jun 1;141(6):1609–21Lire le résumé
Thyoka M, Adekunle O, Pilkington C, Walters S, Arthurs OJ, Humphries P, et al. Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. Rheumatology [Internet]. 2018 Jun 12 [cited 2018 Jul 27];Lire le résumé
Touat M, Maisonobe T, et al. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology. 2018 Aug 8Lire le résumé
Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, et al. Immune checkpoint
inhibitor-related myositis and myocarditis in patients with cancer. Neurology. 2018 Sep 4;91(10):e985–
94
Lire le résumé
Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, et al. Development of a New
Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and
Myositis-Specific Autoantibodies. JAMA Neurology [Internet]. 2018 Sep 10 [cited 2018 Sep 25]
Lire le résumé
Kubo S, Todoroki Y, Nakayamada S, Nakano K, Satoh M, Nawata A, et al. Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies. Rheumatology (Oxford). 2018 Aug 28; Lire le résumé
Mamyrova G, Kishi T, Targoff IN, Ehrlich A, Curiel RV, Rider LG, et al. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology. 2018 Nov 1;57(11):1956–63.Lire le résumé
Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, et al. In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Annals of the Rheumatic Diseases. 2018 Oct 11;annrheumdis-2018-213518.Lire le résumé